使用波纹散射特征自动检测帕金森语音
Mittapalle Kiran Reddy1, Paavo Alku2
1Department of Computer Science and Engineering, Indian Institute of Information Technology Raichur, 584135 Karnataka, India.
JASA express letters
|May 19, 2025
概括
这项研究引入了一种新的方法,通过使用波纹散射网络从语音中检测帕金森病 (PD). 该方法实现了87%的准确性,超过了早期PD诊断的现有技术.
科学领域:
- 生物医学工程 生物医学工程
- 信号处理 信号处理
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 诊断可能具有挑战性,并且通常依赖于主观的临床评估.
- 对PD早期检测的客观,非侵入性方法对于及时干预和管理至关重要.
- 语音分析为识别与PD相关的微妙生理变化提供了一个有希望的途径.
研究的目的:
- 开发和评估使用语音信号检测帕金森病的自动化系统.
- 研究波纹散射网络和费舍尔向量的有效性,以提取PD识别的相关语音特征.
- 将拟议方法的性能与现有的PD检测最先进技术进行比较.
主要方法:
- 分析了PC-GITA数据库中的语音数据.
- 采用双层波纹散射网络,生成局部稳定和翻译不变的语音特征.
- 费舍尔向量被用来将散射特征编码为固定大小的发言级向量.
- 支持矢量机 (SVM) 和前神经网络 (FFNN) 分类器被训练为二元分类 (健康与PD).
主要成果:
- 拟议的方法利用波纹散射特征和费舍尔矢量编码,与当前最先进的方法相比,显示出更高的性能.
- 获得的最佳分类准确率为87%,用于区分患有帕金森病的人与健康对照人.
- 该系统在从文本阅读任务中分析语音时特别有效.
结论:
- 波纹散射网络与费舍尔向量相结合,为从语音中检测帕金森病提供了强大而有效的特征提取策略.
- 开发的自动化系统显示了PD早期和准确诊断的巨大潜力.
- 这种方法提供了一个有希望的,客观的,非侵入性的工具来帮助临床医生诊断帕金森病.
更多相关视频
11:00Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats
Published on: August 8, 2011
19.7K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.7K
相关概念视频
01:24Parkinson's Disease: Treatment
165
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
165
01:15Parkinson's Disease: Overview
395
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
395